TCRab + CD4 − CD8a + CD8b − intestinal intraepithelial lymphocytes (CD8aa IELs) are an abundant population of thymus-derived T cells that protect the gut barrier surface. We sought to better define the thymic IEL precursor (IELp) through analysis of its maturation, localization and emigration. We defined two precursor populations among TCRb + CD4 − CD8 − thymocytes by dependence on the kinase TAK1 and rigorous lineage-exclusion criteria. Those IELp populations included a nascent PD-1 + population and a T-bet + population that accumulated with age. Both gave rise to intestinal CD8aa IELs after adoptive transfer. The PD-1 + IELp population included more strongly self-reactive clones and was largely restricted by classical major histocompatibility complex (MHC) molecules. Those cells localized to the cortex and efficiently emigrated in a manner dependent on the receptor S1PR1. The T-bet + IELp population localized to the medulla, included cells restricted by non-classical MHC molecules and expressed the receptor NK1.1, the integrin CD103 and the chemokine receptor CXCR3. The two IELp populations further differed in their use of the T cell antigen receptor (TCR) a-chain variable region (V a ) and b-chain variable region (V b ). These data provide a foundation for understanding the biology of CD8aa IELs. = A r t i c l e s
Intestinal intraepithelial lymphocytes (IELs) are a heterogeneous T cell population embedded within the intestinal epithelial layer, where they carry out numerous effector, regulatory and protective functions 1, 2 . How IELs exert these functions is not fully understood. IELs include memory TCRαβ + CD4 + cells and TCRαβ + CD8αβ + cells generated from naive T cells during an immune response (induced IELs), and TCRγδ + cells and TCRαβ + CD4 − CD8α + CD8β − cells (CD8αα IELs) that differentiate in the thymus (natural IELs) 2 . The development of natural CD8αα IELs has been the subject of extensive research, yet their precise thymic precursor has remained unknown. Post-selection IEL precursors (IELps) can be found within the CD4 − CD8 − doublenegative (DN) thymocyte population as cells expressing the negative regulator CD5 and the T cell antigen receptor β-chain (TCRβ) [3] [4] [5] , although within this population there is still substantial heterogeneity. Various molecules, including the transcription factor T-bet, the costimulatory molecule PD-1, integrin α 4 β 7 and CD103 (integrin α E ) have been linked to IEL development [4] [5] [6] [7] . However, other features of IEL development are not yet known, including thymic localization, emigration patterns and TCR specificity. Published approaches have suggested variability among CD8αα IELs in their MHC restriction 4, 5 .
Published studies of IELps have relied on NK1.1 as an exclusion marker for invariant natural killer T cells (iNKT cells). That approach, however, does not exclude the thymic iNKT cell subsets that are NK1.1 − : NKT2 cells and NKT17 cells 8 . Here we investigated the development and emigration of thymic IELps in detail through the use of a tetramer linked to the antigen-presenting molecule CD1d (CD1dtet) to specifically exclude iNKT cells. We discovered two distinct mature DN T cell subsets of different phenotype that were able to differentiate into CD8αα IELs. One was PD-1 + and showed enrichment for self-reactive cells, which confirmed in a polyclonal setting what had previously been found in a retrogenic model 5 . The second subset was a previously unrecognized PD-1 − T-bet + population with high expression of NK1.1. This population did not show signs of overt self-reactivity, in contrast to the PD-1 + population, and included non-classical MHC class I-restricted cells. The two subsets further differed in their use of TCRα and TCRβ chains and underwent emigration from the thymus with different efficiency. Even though T-bet + IELps had a more mature 'IEL-like' phenotype, the main emigrating IELps were PD-1 + and expressed integrin α 4 β 7 . Both IELp populations were able to seed the gut, where they expressed CD8αα, and since the PD-1 + IELp population downregulated the expression of PD-1 and increased the expression of T-bet, cells arising from the two progenitor populations were largely indistinguishable in the gut environment through the use of conventional markers. Our study reconciles variability in phenotypes and MHC restriction reported for IELps, in addition to revealing previously unknown aspects of IELp development and functionality.
RESULTS
A mature IELp population among thymic TCRb + DN cells Published data have suggested that IELps can be found within the TCRβ + CD5 + CD4 − CD8 − DN gate 3, 5 . We used that gating strategy and further excluded iNKT cells (using a CD1dtet loaded with the cognate antigen analog PBS57) and CD25 + regulatory T cells (Fig. 1a) .
Within this DN population, approximately one third had a mature phenotype, as indicated by increased expression of the MHC class I molecule H-2K b (ref. 9) , and H-2K b+ cells had high expression of the cytokine receptor subunit CD122 (IL-2Rβ; shared with the receptor for the cytokine IL-15) ( Fig. 1b) . TCRβ + mature T cells require the kinase TAK1 for maturation 9 . Analysis of Tak1 fl/fl Cd4 Cre mice (in which loxP-flanked Tak1 alleles (Tak1 fl/fl ) are deleted by Cre recombinase expressed from the promoter of the gene encoding the monomorphic co-receptor CD4 (Cd4 Cre )) confirmed the selective absence of CD8αα IELs, but not of TCRγδ + IELs, in the small intestine ( Fig. 1c) , as previously reported 10 . Correspondingly, we observed fewer CD122 + H-2K b+ DN thymocytes in TAK1-deficient mice than in TAK1-sufficient (Tak1 fl/fl ) mice ( Fig. 1b) , which suggested that this population represented mature precursor cells. Wild-type mature CD122 + (H-2K b+ ) cells among the total CD5 + TCRβ + DN population also had little expression of the C-type lectin CD69 ( Fig. 1d) , analogous to mature conventional thymocytes. These results indicated that within the CD25 − CD1dtet − CD5 + TCRβ + DN population, mature cells, including mature IELps, could be identified as CD122 + H-2K b+ cells. We used this gating strategy for mature IELps throughout the studies reported here, unless indicated otherwise.
Two main subsets of mature TCRb + DN cells
We reasoned that within the mature DN population, IELps might express molecules critical for the development of CD8αα IELs, such as the transcription factor T-bet (encoded by Tbx21) 6 . Within the mature TCRβ + DN population from mice expressing a green fluorescent protein (GFP) as a reporter for T-bet (Tbx21 GFP ), distinct GFP − and GFP hi cells were present ( Fig. 2a) . IELs have been suggested to arise from precursor cells diverted from clonal deletion in response to strong TCR signaling 5, 11, 12 . PD-1 expression is upregulated by TCR signaling, and PD-1 has been shown to be expressed on DN thymocytes in mice expressing retrogenic IEL TCRs 5 . Notably, only the DN cells lacking T-bet had abundant expression of PD-1 ( Fig. 2b) . Furthermore, in mice expressing GFP as a reporter for the orphan nuclear receptor Nur77 (encoded by Nr4a1; Nr4a1 GFP ), only the PD-1 + cells had high expression of GFP ( Fig. 2b) , indicative of recent and strong TCR stimulation. Consistent with the proposal of clonal deletion as an alternative fate for IELps, the frequency and number of PD-1 + DN cells was 35-fold greater in the thymus of mice deficient in the proapoptotic protein Bim (Bim −/− ; a model in which normally deleted T cells are 'rescued' 13 ) than in that of Bim +/+ mice ( Fig. 2c) . It is possible that the PD-1 + cells were precursors to PD-1 − T-bet + cells and had experienced strong TCR signaling only transiently before upregulating their T-bet expression. Although Bim −/− mice had more PD-1 − mature DN cells than Bim +/+ mice had, this difference was much smaller than that for the PD-1 + population (Fig. 2c) . In addition, mice deficient in the costimulatory receptor CD28 (Cd28 −/− ), in which self-reactive thymocytes are diverted into the CD8αα IEL lineage 11 , had only more PD-1 + mature DN cells, not more PD-1 − mature DN cells, than Cd28 +/+ mice had ( Fig. 2d) . These characteristics suggested that the PD-1 + (T-bet − ) and PD-1 − (T-bet + ) cells might represent separate lineages; thus, we called these 'type A' IELps and 'type B' IELps, respectively.
The integrins α 4 β 7 and α E (CD103) have been associated with homing to and retention in gut [14] [15] [16] ; thus, we assessed the expression of these molecules on thymic progenitors. Type A IELps were the predominant α 4 β 7 -expressing cells, while only type B IELps expressed CD103 ( Fig. 2e) . As T-bet expression in the thymus is high in iNKT cells 8, 17 , we also searched for other NKT cell-related molecules. Indeed type B IELps were NK1.1 + , but type A IELps were not ( Fig. 2f) , although neither type A IELps nor type B IELps bound CD1dtet ( Fig. 1a) . Type B IELps also expressed yellow fluorescent protein (YFP) in mice expressing YFP as a reporter for interferon-γ (IFN-γ, encoded by Ifng; Ifng YFP ) ( Fig. 2g) .
To further explore whether the type A IELps and type B IELps represented distinct progenitor cells, we employed spanning-tree analysis ('spanning-tree progression analysis of density-normalized events' (SPADE)) 18, 19 with an extended marker panel. All TCRβ hi (post-selection) thymocytes were included in the analysis, and major clusters of CD4 + CD8 + double-positive (DP) cells, mature CD4 + single-positive (CD4SP) cells and mature CD8 + single-positive (CD8SP) cells were identified ( Fig. 2h and Supplementary Fig. 1a-l) . A cluster of Tbx21 GFP+ cells was located off the CD4SP cell branch, which included CD1dtet-binding iNKT cells but contained two nodes of CD1dtet − cells that matched the phenotype of type B cells (Fig. 2h,j and Supplementary Fig. 1b-i) . In contrast, the only nodes that corresponded to type A IELps emerged near the DP progenitor group (Fig. 2h,j and Supplementary Fig. 1b-i) . Quantification revealed a ratio of type A IELps to type B IELps similar to that in the total thymus, as assessed by our flow-cytometry gating strategy ( Fig. 2a,i) . We further found that the activation and memory marker CD44 and the chemokine receptor CXCR3 were expressed by type B IELps but not by type A IELps ( Fig. 2j and Supplementary Fig. 1j,l) . Both cell types were negative for CCR7 ( Fig. 2j and Supplementary Fig. 1k ), a chemokine receptor associated with the migration of developing T cells from the thymic cortex to the medulla 20, 21 . In conclusion, we identified two main subtypes within the mature TCRβ + DN cell population distinguished by expression of PD-1 or of T-bet and NK1.1.
Both type A IELps and type B IELps give rise to CD8aa IELs
To assess the ability of each mature DN subtype to develop into CD8αα IELs, we adoptively transferred sorted type A IELps or type B IELps together with congenically distinct total CD4 − CD8 − DN control thymocytes into immunodeficient (Rag2 −/− ) recipient mice and recovered cells from the spleen and the epithelium of the small intestine of the host mice 5-10 weeks later. While TCRβ + control competitor cells gave rise to heterogeneous CD4 + or CD8 + cells in both the IEL compartment as well as the spleen, type A IELps and type B IELps gave rise almost exclusively to CD8αα + IELs in the intestine ( Fig. 3a and Supplementary Fig. 2a ). That strong fate determination was tissue specific, as the spleen did not show significant enrichment for CD8αα + descendants of either IELp subset ( Supplementary Fig. 2b ). Type A IELps and type B IELps competed
Hi Med Events (% of max) A r t i c l e s equivalently with the control cells, and experiments in which type A IELps were transferred together with type B IELps resulted in similar outcomes (data not shown), which suggested that both progenitor cells had a robust potential to seed the gut, at least in Rag2 −/− recipient mice.
Type A IELps are nascent; type B IELps accumulate with age CD103 expression is associated not only with IELs and IELps 2,6 but also with tissue-resident T cells 22 . We were therefore interested in determining if type B IELps were retained in the thymus. For this, we made use of Rag2 GFP mice, in which thymocytes at the DP stage have high expression of GFP and this protein degrades over time after positive selection 23, 24 . While type A IELps exhibited Rag2 GFP expression similar to that of developing CD4SP thymocytes, type B IELps were Rag2 GFP− (Fig. 3b) , which suggested that the latter population was older or had proliferated extensively. As GFP would be diluted by proliferation, we assessed cell-cycle activity via the proliferation marker Ki67. Type B IELps had much lower expression of Ki67 than that of type A IELps (Fig. 3c) , which indicated that the depletion of GFP was not due to recent proliferation. In addition, type B IELps had high expression of the maturation marker Qa2, with its intensity far exceeding that in type A IELps (Fig. 3d) . Furthermore, while the absolute number of type A IELps decreased, the type B IELp population accumulated, with increasing age of mice ( Fig. 3e) .
Of note, those findings were not due to recirculation of type B IELps, as indicated by adoptive transfer and parabiosis studies (data not shown). In summary, type A IELps seemed to be developmentally younger than type B IELps, with the latter expressing markers indicative of retention in the thymus. Nevertheless both types of cells, once in circulation, had an inherent ability to seed an open niche and become CD8αα + IELs.
Type A IELps and type B IELps localize differently in the thymus
The chemokine receptors CXCR4 and CCR9 are expressed predominantly by DP thymocytes and are thought to be involved in the cortical localization of those cells [25] [26] [27] . On the other hand, expression of CCR4 and CCR7 is induced after positive selection and is associated with migration of thymocytes from the cortex to the medulla 20, 21, 26, 28 . Both IELp types (A and B) were devoid of surface expression of CCR9 and had negative or low expression of CXCR4 ( Fig. 4a) , consistent with their post-selection maturation status. However, neither IELp type expressed CCR4 or CCR7. CXCR3 expression has been suggested to retain iNKT cells in the medulla 29 . Type B IELps were CXCR3 + , consistent with our SPADE results, but type A IELps were not. Given these patterns, it was not easy to predict where each precursor would be localized within the thymus.
To directly investigate that, we devised an immunofluorescence staining strategy. Flow-cytometry-based back-gating showed that among total thymocytes, PD-1 hi Nr4a1 GFPhi cells were predominantly CD5 + TCRβ + DN cells (Supplementary Fig. 3a) . Total Tbx21 GFPhi CD1dtet − thymocytes were largely CD5 + TCRβ + DN cells that included mainly mature type B IELps (Supplementary Fig. 3b ). Thus, we employed immunofluorescence-based quantitative histocytometry 30 using PD-1, Nr4a1 GFP , Tbx21 GFP and CD1dtet to determine the localization of type A and type B IELps in the thymus. Comparison of flow cytometry to quantitative immunofluorescence revealed that imaging identified a greater proportion of both IELp types than did flow cytometry (Fig. 4b,e ). That was in agreement with a publication reporting that cell isolation and flow cytometry can underestimate the number of T cells 31 . We next quantified the localization of gated events: 70% of PD-1 hi Nr4a1 GFPhi (type A) IELps were in the cortex, while the remaining 30% were typically in the cortico-medullary junction (Fig. 4b-d and not shown). In contrast, 75% of Tbx21 GFPhi CD1dtet − (type B) IELps were present in the medulla (Fig. 4e-g) .
As IL-15 is a cytokine that can induce T-bet expression 6 , and iNKT cells in the thymus are suggested to depend on IL-15 trans-presented by medullary thymic epithelial cells 32 , we assessed the effects of IL-15 deficiency on IELps. Lethally irradiated Il15 −/− mice reconstituted with Tbx21 GFP bone marrow cells were found to be depleted of type B IELps, while type A IELps were still present in these mice (Supplementary Fig. 3c) . Notably, CD122 expression by mature IELps was not affected in those Il15 −/− chimeras ( Supplementary  Fig. 3c) . These results suggested 'preferential' localization of type A IELps to the cortex of the thymus versus 'preferential' localization of type B IELps to the medulla of the thymus. 
A r t i c l e s
Emigration of type A IELps is dominant over that of type B IELps We next investigated the emigration properties of IELp. The emigration of conventional T cells and IELps from the thymus is mediated by the G-protein-coupled receptor S1PR1 targeted by the transcription factor KLF2 (refs. [33] [34] [35] . Among the mature IELp population, 14% of the cells were Klf2 GFP+ S1PR1 + (Supplementary Fig. 4a ). Reciprocally, most of the Klf2 GFP+ S1PR1 + cells among total CD4 − CD8α − CD5 + TCRβ + IELps were CD122 + H-2K b+ (Supplementary Fig. 4b) . The Klf2 GFP+ S1PR1 + mature IELp population contained mainly type A IELps, which included a significantly higher proportion of α 4 β 7 + cells than did the total mature type A IELp population (Fig. 5a) . This suggested that type A IELps expressed α 4 β 7 as they became emigration-competent.
Intravenous labeling with phycoerythrin-conjugated antibody to CD4 has been used to define CD4SP thymocytes that are emigrating, as they are thought to do so from perivascular spaces at the corticomedullary boundary 36 . We employed a similar technique for IELps and found that among the labeled fraction, type A IELps were more abundant than type B IELps and showed further enrichment relative to the abundance of the unlabeled parenchymal IELps (Fig. 5b) .
In a further approach, we defined peripheral recent thymic emigrants (RTEs) by ultrasound-guided intrathymic biotin labeling (Supplementary Fig. 5a ) and analysis of streptavidin-positive cells in the spleen 24 h later (Supplementary Fig. 5b) . Type A IELps showed enrichment among the splenic RTEs, relative to their proportion in the thymus tissue ( Fig. 5c) , in agreement with the enrichment for type A IELps in the intravenously labeled fraction (Fig. 5b) . In contrast, RTE populations had a lower proportion of type B IELps than the proportion of type B IELps in the thymus tissue (Fig. 5c) .
To determine if type A IELps emigrated in an S1PR1-dependent fashion, we treated Rag2 GFP mice with FTY720, a functional antagonist of S1PR1, for 6 consecutive days. The frequency of GFP + splenic CD1dtet − CD25 − TCRβ + cells was much lower in FTY720-treated mice than in untreated mice, as expected (Supplementary Fig. 5c ). DN cell populations within this fraction were almost entirely depleted of mature-phenotype IELps (Supplementary Fig. 5c ). Of note, the mature IELps in untreated mice were predominantly PD-1 + α 4 β 7 + ( Supplementary Fig. 5c ), consistent with the enrichment for these cells in the Klf2 GFP+ S1PR1 + compartment of mature IELps. These results suggested that type A IELps were the main population exiting the thymus at steady state and that their emigration was S1PR1 dependent. However, our data also indicated that despite being retained in the thymus, a small fraction of type B IELps also emigrated.
Type B IELps do not arise from type A IELps
We analyzed IELps in FTY720-treated mice to investigate the effects of retention on their phenotype. Notably, type A IELps trapped in the thymus via treatment with FTY720 gradually lost their surface expression of PD-1 and began to express Tbx21 GFP (Supplementary  Fig. 6a ). Bin gating on PD-1 hi (gate 1), PD-1 int (gate 2), PD-1 lo (gate 3) and PD-1 − (gate 4) mature IELps revealed an increase in numbers at all these stages (Supplementary Fig. 6a) . Notably, we also found an increase in α 4 β 7 expression at the PD-1 int , PD-1 lo and PD-1 − stages (Supplementary Fig. 6b) , consistent with the accumulation of a trapped type A IELp population that began to differentiate toward a type B IELp phenotype. However, the population of Tbx21 GFPhi type B IELps remained α 4 β 7 − and constant in number despite administration of FTY720 for 6 d (Supplementary Fig. 6a,c) .
To more rigorously investigate the possibility of an immediate precursor-product relationship between type A IELps and type B IELps, we performed 'time-stamp' experiments. For this we used reporter mice obtained from the crossing of Cd4 CreERT2 mice (with tamoxifen-inducible expression of Cre from Cd4) with mice Rosa26 floxedSTOPTdT mice (in which a loxP-flanked STOP cassette (floxedSTOP) precludes expression the red fluorescent protein tdTomato (TdT)). Treatment of these Cd4 CreERT2 × Rosa26 floxedSTOPTdT mice with tamoxifen results in permanent labeling of every DP or CD4 + cell with tdTomato at the time of exposure. Although neither type A IELps nor type B IELps expressed CD4, they were both derived from DP progenitor cells (data not shown). Therefore, this approach allowed the labeling of a cohort of DP progenitor cells and tracking through differentiation thereafter. After intraperitoneal administration of tamoxifen, tdTomato expression was detected only in DP thymocytes on day 2 but was present in CD8SP cells on day 5 (Fig. 6) . Similar to CD8SP cells, the type A IELp population displayed a peak of tdTomato + cells 5 d after tamoxifen treatment that was diminished at 10 d after tamoxifen treatment, consistent with emigration of these populations. No tdTomato + cells were found in the type B IELp pool, which would be expected if type A IELps differentiated into type B IELps. Thus, while type A IELps were able to downregulate their expression of PD-1 and expressed Tbx21 GFP when forcibly retained in the thymus, these cells did not contribute substantially to the type B IELp pool at steady state.
Differential antigen-receptor specificities in IELp types
We were interested in finding out more about potential functional properties of type A IELps versus those of type B IELps. Through 
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Rag2 GFP IELps (%) Figure 5 The emigration of type A IELps is dominant over that of type B IELps. (a) Frequency of type A and type B IELps (key) among Klf2 GFP + S1PR1 + mature IELps from Klf2 GFP mice further stained for S1PR1 ( Supplementary Fig. 4a ) (left), and of α 4 β 7 + cells among the total mature (mat) type A IELp population or Klf2 + S1PR1 + mature type A IELps (key) from those mice (right). (b) Frequency of type A and type B IELps (key) with a mature phenotype among TCRβ + cells of the unlabeled (IV − ) and labeled (IV + ) thymic fractions of mice intravenously labeled with phycoerythrinconjugated antibody to the congenic marker CD45.2 ( Supplementary Fig. 4c ). the investigation of a small number of clones in retrogenic mice, it has been established that CD8αα IELs can be restricted by various MHC classes 4, 5 . Similarly to published results 11, 37 , we found that β 2microglobulin-deficient (B2m −/− ) mice had considerably fewer IELs than did wild-type mice (Fig. 7a) . That finding was recapitulated by the presence of fewer type A IELp thymocytes and type B IELp thymocytes in B2m −/− mice than in wild-type mice, although the reduction was much larger in the gut (100-fold) than in the thymus (3-to 6-fold) (Fig. 7a) . Conversely, only type A IELps were affected by deficiency in the classical MHC molecules H2-K b and H2-D b (Fig. 7a) , consistent with restriction of type B IELps by non-classical MHC class I molecules. The number of type B IELps (even after gating exclusively on PD-1 + NK1.1 + ) was also lower in Cd1 −/− mice, which lack expression of CD1d, than in wild-type mice (Fig. 7b) , suggestive of the existence of type 2 NKT cells within this population. Deficiency in the MHC class II molecule I-A b did not significantly affect type A IELps but slightly diminished the number of type B IELps (Fig. 7c) . Together our data suggested differential MHC restriction of type A IELps relative to that of type B IELps and indicated greater involvement of β 2 -microglobulin-dependent molecules in the maintenance of IELs in the gut than in selection in the thymus.
In addition to their differential dependence on MHC, the two IELp types also varied in use of the TCR α-chain. In a comparison of α-chain variable region 2 (V α 2) and V α 3.2, type A IELps showed the greatest use of V α 2, while type B IELps were dominated by use of V α 3.2 (Fig. 7d) . Notably, the proportion of both V α 2 + IELs and V α 3.2 + IELs was intermediate between that of thymic type A IELps and type B IELps (Fig. 7d) . Given the lower thymic output of type B IELps, this might reflect either greater population expansion of V α 3.2 + IELs within the gut or a greater ability of type B IELps to seed the IEL A r t i c l e s niche despite their absence of α 4 β 7 . We also investigated the β-chain variable region (V β ) repertoire of type A and type B IELps. Among 14 V β chains analyzed, we found significantly less use of V β 5.1-V β 5.2 and V β 9 and significantly more use of V β 6 by type B IELps than by type A IELps (Supplementary Fig. 7) . Thus, in addition to their phenotypic differences, type A IELps and type B IELps also varied in their MHC dependence and TCR use, suggestive of distinct antigen specificities and potential functions of these two subtypes.
DISCUSSION
Thymic precursors of intestinal CD8αα IELs and their maturation, localization and emigration have not been fully characterized. In this study, we investigated these parameters and have provided detailed analysis to this end. Our findings suggested the existence of two distinct subsets of mature IELps that we called 'type A' IELps and 'type B' IELps. The type A IELps were localized in the cortex and showed signs of strong agonist signaling. Thus, they had the expected characteristics of cells undergoing 'clonal diversion' at the DP stage. In contrast, type B IELps resided in the medulla and included few or no self-reactive cells. The majority of type B IELps were NK1.1 + and would have been excluded from analysis in previously published studies using NK1.1 as an exclusion marker. Our data support a model in which in addition to the 'mainstream' type A IELps, type B IELps with potentially different antigen specificity and function diversify the gut IEL repertoire.
In terms of the developmental relationship, we considered the possibility that type B IELps were derived from type A IELps. However, the 'rescue' of type A IELps, but not that of type B IELps, in Bim −/− mice and Cd28 −/− mice, as well as the distinct TCR use and MHC dependence of these cells, challenge that proposal. Though we cannot exclude the possibly that a proportion of the type B IELps might have been derived from cells in the type A IELp pool, we favor the idea that the majority of type A IELps and type B IELps are on parallel developmental pathways rather than linear developmental pathways, a proposal further supported by our time-stamp experiments. Concordantly, SPADE placed type B IELps in close relationship with CD4SP and iNKT cells, while type A IELps branched off from the DP pool. Our data also showed a differential effect of MHC deficiency on IELps. The number of type A IELps was affected most by deficiency in classic MHC class I and β 2 -microglobulin, while the number of type B IELps was affected by deficiency in MHC class II, CD1d and β 2 -microglobulin. Those findings were in line with published reports showing restriction of individual retrogenic IEL clones by various classical and non-classical MHC molecules 4, 5 . Due to a lack of specific markers on IELs derived from type A IELps and type B IELps, we were unable to determine the relative proportion of gut-resident lymphocytes derived from each. However, thymic type A IELps and B IELps showed different use of TCR V α , and their use of TCR V α was intermediate among that of IELs, which suggested that progeny of both were present in the gut.
The thymic localization and emigration properties versus the retention properties of the two precursor populations was clearly distinct. About 25-30% of type A IELps were located in proximity to the cortico-medullary junction, and we think it likely that these cortico-medullary IELps were about to emigrate from the thymus, similarly to conventional T cells 36 . How type B IELps, which were CCR4 − and CCR7 − , migrated toward and were retained in the medulla was not clear. We considered the possibility that like iNKT cells 29 , CXCR3 + type B IELps were retained by CXCR3 ligands derived from medullary thymic epithelial cells. However, we did not find differences in the proportion of type A IELps or type B IELps in Cx3cr −/− mice relative to that in their wild-type littermates (data not shown). In addition, medullary IL-15 might have a role in this: in agreement with a study showing that IELs can develop without thymic IL-15 (ref. 38) , Il15 −/− chimeras reconstituted with Tbx21 GFP bone marrow cells had a considerably lower proportion of type B IELps, but not of type A IELps, than that of wild-type chimeras reconstituted with Tbx21 GFP bone marrow cells. It is therefore possible that type B IELps might accumulate in the medulla due to their dependence on IL-15. Type B IELps were similar to NKT1 cells in that they were IL-15 dependent and T-bet + CD44 hi CXCR3 + IFN-γ + , were largely retained in the thymus and also 'preferentially' localized to the medulla 8, 17 . That similarity would indicate a mutual, albeit unidentified, function in the thymus. Notably, differential MHC restriction and thymic localization also indicate selection by different cell types rather than by one specific antigen-presenting cell. These aspects should be explored further in future studies. S1PR1 expression, under control of the transcription factor KLF2, has been established as a critical factor for the emigration of conventional T cells 33, 34 . While the contribution of S1PR1 to the trafficking of IELps from thymus to gut has been previously investigated 35, 39 , its involvement specifically in the egress of IELps from the thymus has remained controversial. Our findings suggested that type A IELps required this molecule for exiting the thymus. Of note, populations of S1PR1 + type A IELps and RTEs showed further enrichment for α 4 β 7 -expressing cells that promote homing to mucosal tissues 14, 15 . Indeed, the complete absence of type A IELps in the spleen of mice treated for 6 d with an S1PR1 antagonist indicated swift 'parking' in the gut and possibly other mucosal sites, or death, rather than extended circulation. Although we did not investigate this for the minor population of emigrating type B IELps, they might have the same S1PR1-dependent mechanism for exit from the thymus.
In summary, we have identified two subsets of mature thymocytes distinguished by phenotype, TCR specificity and MHC restriction: type A IELps and type B IELps. Both were able to give rise to CD8αα IELs in the small intestine. Given their disparities, functional differences between type A IELps and type B IELps are likely. Thus, the findings of this study should affect future expression-profiling studies and elucidation of the roles of IELs in homeostasis and immunity and how they relate to human IEL populations.
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